Literature DB >> 12447930

Selective neurodegeneration in murine mucopolysaccharidosis VII is progressive and reversible.

Gregory G Heuer1, Marco A Passini, Kanli Jiang, Michael K Parente, Virginia M-Y Lee, John Q Trojanowski, John H Wolfe.   

Abstract

The mucopolysaccharidoses are caused by inherited deficiencies of lysosomal enzymes involved in the degradative pathway of glycosaminoglycans. Lysosomal storage leads to cellular and organ dysfunction, including mental retardation. Storage lesions are found throughout the diseased brain, but little is known about the cellular and molecular mechanisms that underlie brain dysfunction. In the mouse model of mucopolysaccharidosis VII, we found that specific regions of the brain are vulnerable to neurodegeneration, characterized by the presence of ubiquitin inclusions, neurofilament inclusions, and reactive astrogliosis. The pathological lesions were found predominantly in the hippocampus and cerebral cortex, and they increased progressively with age. Treatment with a recombinant viral vector to correct the enzymatic defect quantitatively reversed the neurodegenerative lesions in targeted regions to normal levels.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12447930     DOI: 10.1002/ana.10373

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  20 in total

1.  Transgene expression in target-defined neuron populations mediated by retrograde infection with adeno-associated viral vectors.

Authors:  Markus Rothermel; Daniela Brunert; Christine Zabawa; Marta Díaz-Quesada; Matt Wachowiak
Journal:  J Neurosci       Date:  2013-09-18       Impact factor: 6.167

2.  Transplantation and magnetic resonance imaging of canine neural progenitor cell grafts in the postnatal dog brain.

Authors:  Raquel M Walton; Sergey G Magnitsky; Gabriela S Seiler; Harish Poptani; John H Wolfe
Journal:  J Neuropathol Exp Neurol       Date:  2008-10       Impact factor: 3.685

3.  Lessons learnt from animal models: pathophysiology of neuropathic lysosomal storage disorders.

Authors:  Kim M Hemsley; John J Hopwood
Journal:  J Inherit Metab Dis       Date:  2010-05-07       Impact factor: 4.982

4.  Integrated analysis of proteome and transcriptome changes in the mucopolysaccharidosis type VII mouse hippocampus.

Authors:  Michael K Parente; Ramona Rozen; Steven H Seeholzer; John H Wolfe
Journal:  Mol Genet Metab       Date:  2016-03-07       Impact factor: 4.797

5.  High-resolution magnetic resonance microscopy and diffusion tensor imaging to assess brain structural abnormalities in the murine mucopolysaccharidosis VII model.

Authors:  Manoj Kumar; Ilya M Nasrallah; Sungheon Kim; Ranjit Ittyerah; Stephen Pickup; Joel Li; Michael K Parente; John H Wolfe; Harish Poptani
Journal:  J Neuropathol Exp Neurol       Date:  2014-01       Impact factor: 3.685

6.  Lysosomal accumulation of SCMAS (subunit c of mitochondrial ATP synthase) in neurons of the mouse model of mucopolysaccharidosis III B.

Authors:  Sergey Ryazantsev; Wei-Hong Yu; Hui-Zhi Zhao; Elizabeth F Neufeld; Kazuhiro Ohmi
Journal:  Mol Genet Metab       Date:  2006-12-20       Impact factor: 4.797

7.  A GLP-Compliant Toxicology and Biodistribution Study: Systemic Delivery of an rAAV9 Vector for the Treatment of Mucopolysaccharidosis IIIB.

Authors:  Aaron S Meadows; F Jason Duncan; Marybeth Camboni; Kathryn Waligura; Chrystal Montgomery; Kimberly Zaraspe; Bartholomew J Naughton; William G Bremer; Christopher Shilling; Christopher M Walker; Brad Bolon; Kevin M Flanigan; Kim L McBride; Douglas M McCarty; Haiyan Fu
Journal:  Hum Gene Ther Clin Dev       Date:  2015-12       Impact factor: 5.032

8.  Long-term AAV vector gene and protein expression in mouse brain from a small pan-cellular promoter is similar to neural cell promoters.

Authors:  T Husain; M A Passini; M K Parente; N W Fraser; J H Wolfe
Journal:  Gene Ther       Date:  2009-05-21       Impact factor: 5.250

9.  Magnetic resonance imaging detects differences in migration between primary and immortalized neural stem cells.

Authors:  Sergey Magnitsky; Raquel M Walton; John H Wolfe; Harish Poptani
Journal:  Acad Radiol       Date:  2008-10       Impact factor: 3.173

10.  Feasibility and safety of systemic rAAV9-hNAGLU delivery for treating mucopolysaccharidosis IIIB: toxicology, biodistribution, and immunological assessments in primates.

Authors:  Darren A Murrey; Bartholomew J Naughton; F Jason Duncan; Aaron S Meadows; Tierra A Ware; Katie J Campbell; William G Bremer; Christopher M Walker; Laurie Goodchild; Brad Bolon; Krista La Perle; Kevin M Flanigan; Kim L McBride; Douglas M McCarty; Haiyan Fu
Journal:  Hum Gene Ther Clin Dev       Date:  2014-04-10       Impact factor: 5.032

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.